-
US FDA postpones foreign inspections over coronavirus outbreak
expresspharma
March 12, 2020
According to Stephen M Hahn, Commissioner of Food and Drugs – Food and Drug Administration, the foreign inspections will resume as soon as feasible.
-
WHO publishes R&D roadmap for coronavirus Covid-19
pharmaceutical-technology
March 11, 2020
The World Health Organization (WHO) has published research and development (R&D) roadmap to address coronavirus Covid-19.
-
Coronavirus Disease 2019 (COVID-19) Update: Foreign Inspections
FDA
March 11, 2020
The FDA updated on the status of U.S. Food and Drug Administration inspections outside of the U.S. in response to the COVID-19 outbreak.
-
CEL-SCI Developing Immunotherapy to Treat Coronavirus
contractpharma
March 10, 2020
Will leverage LEAPS peptide technology to reduce COVID-19 viral load and tissue damage resulting from infection in the lungs.
-
Beroni Group Advances Coronavirus Research
contractpharma
March 10, 2020
Identifies nanobody sequence and complex crystal structure of SARS-CoV-2, the virus causing the infection.
-
Coronavirus Update: FDA and FTC Warn Seven Companies Selling Fraudulent Products that Claim to Treat or Prevent COVID-19
PRNewswire
March 10, 2020
The U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) issued warning letters to seven companies for selling fraudulent COVID-19 products. These products are unapproved drugs that pose significant risks to patient health and vi
-
Arcturus Therapeutics partners with medical school for coronavirus vaccine
pharmaceutical-technology
March 09, 2020
Arcturus Therapeutics, a RNA medicines company, and Duke-NUS Medical School have partnered to develop a coronavirus Covid-19 vaccine for Singapore.
-
Research and Markets Releases COVID 19 Clinical Trials Insight
contractpharma
March 09, 2020
More than 30 clinical trials are being conducted at the global level, with hundreds of patients enrolled.
-
Recipharm Sees Increased Demand for Chloroquine Phosphate
contractpharma
March 09, 2020
Interest is due to chloroquine's antiviral effects, which has potential use in treating coronavirus.
-
No shortage of drug ingredients for next three months; daily monitoring of coronavirus situation: Govt
expresspharma
March 06, 2020
All initiatives are being taken to ensure there is no impact of the disease in India, Minister of Chemicals and Fertilizers D V Sadananda Gowda said.